Updates on Aflibercept BPCIA Litigation - January 2023 | Goo

On January 10, 2024, Regeneron Pharmaceuticals, Inc. (“Regeneron”) filed a Complaint in the U.S. District Court for the Central District of California against Amgen Inc. (“Amgen”)...

Related Keywords

California , United States , West Virginia , , Amgen , Regeneron Pharmaceuticals Inc , Us District Court , Amgen Inc , Filed Complaint Against Amgen , Regeneron Pharmaceuticals , Central District , Judicial Panel , Multidistrict Litigation , Northern District , Chief Judge Kleeh , Samsung Bioepis , Big Molecule Watch ,